Skip to main content

Table 2 Comparison of in vitro drug susceptibility profiles between M. intracellulare and M. avium isolates

From: Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016

Antimicrobial agents

No. of resistant isolates (%)

P value

M. avium

(n = 95)

M. intracellulare

(n = 159)

Clarithromycin

4 (4.2)

6 (3.8)

1.000

Moxifloxacin

5 (5.3)

8 (5.0)

1.000

Linezolid

11 (11.6)

13 (8.2)

0.370

  1. The breakpoints to establish susceptibility and resistance for clarithromycin, moxifloxacin and linezolid were followed as recommendation from Clinical and Laboratory Standards Institute (CLSI-M24-A2)